Amynas

Foundation date

23/12/2019

Sector

#Medical Technology

Subsector

Amynas’ lead candidate product is a bio-envelope made of electrospun nanofibers designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate, resulting in fewer re-admission rates for post-surgical complications.

Upcoming events

Latest news

  • New way of twisting fibers improves energy storage in wearable devices

    Friday November 22nd 2024

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    Thursday November 21st 2024

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    Wednesday November 20th 2024